Rekombinanter TGFB1 Antikörper
Kurzübersicht für Rekombinanter TGFB1 Antikörper (ABIN7857829)
Target
Alle TGFB1 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Expressionssystem
- CHO Cells
-
Verwendungszweck
- Recombinant Transforming Growth Factor Beta 1 (TGFB1) (Marker of Tumor Invasiveness) Antibody
-
Spezifität
- Transforming growth factor beta (TGFB) is a potent cell regulatory polypeptide homodimer of 25 kD. It variably affects cell growth, differentiation and other aspects of cellular metabolism such as extracellular matrix production. Its effect depends upon the cell type and other growth factors present but in general, TGFB inhibits the growth of epithelial cells and stimulates the growth of mesenchymal cells.
-
Aufreinigung
- 200ug/ml of Ab produced in CHO cell mammalian-based expression system.
-
Immunogen
- Prokaryotic recombinant protein corresponding to the full length mature transforming growth factor beta1 molecule
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Andere Bezeichnung
- Transforming Growth Factor Beta 1
-
Hintergrund
-
TGFB | TGFB1 | Transforming growth factor beta-1 proprotein
Human placenta.
-
Molekulargewicht
- 13kDa
-
Gen-ID
- 7040
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Target
-